Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Operating Margin (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Operating Margin for 17 consecutive years, with 21.01% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 1656.0% to 21.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.56% through Dec 2025, up 3670.0% year-over-year, with the annual reading at 9.56% for FY2025, 3671.0% up from the prior year.
  • Operating Margin for Q4 2025 was 21.01% at Bristol Myers Squibb, down from 2.63% in the prior quarter.
  • The five-year high for Operating Margin was 1.8% in Q1 2023, with the low at 121.77% in Q1 2024.
  • Average Operating Margin over 5 years is 14.01%, with a median of 6.58% recorded in 2022.
  • The sharpest move saw Operating Margin tumbled -12357bps in 2024, then soared 12122bps in 2025.
  • Over 5 years, Operating Margin stood at 4.16% in 2021, then tumbled by -55bps to 6.44% in 2022, then tumbled by -45bps to 9.33% in 2023, then plummeted by -303bps to 37.57% in 2024, then skyrocketed by 44bps to 21.01% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 21.01%, 2.63%, and 13.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.